CELC Celcuity Inc. Stock Quote

publish chart | save to portfolio | create alert

CELC [NASD]

Celcuity Inc.

Healthcare | Diagnostics & Research | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.85	Insider Own	39.00%	Shs Outstand	10.27M	Perf Week	10.63%
Market Cap	103.35M	Forward P/E	-	EPS next Y	-1.06	Insider Trans	0.00%	Shs Float	5.03M	Perf Month	79.82%
Income	-8.70M	PEG	-	EPS next Q	-0.22	Inst Own	18.60%	Short Float	0.42%	Perf Quarter	74.73%
Sales	-	P/S	-	EPS this Y	2.60%	Inst Trans	-8.09%	Short Ratio	2.81	Perf Half Y	-7.14%
Book/sh	1.34	P/B	7.38	EPS next Y	-37.70%	ROA	-49.70%	Target Price	13.50	Perf Year	-1.00%
Cash/sh	-	P/C	-	EPS next 5Y	14.00%	ROE	-52.60%	52W Range	4.03 - 12.70	Perf YTD	-7.05%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-22.13%	Beta	-
Dividend %	-	Quick Ratio	13.50	Sales past 5Y	-	Gross Margin	-	52W Low	145.41%	ATR	0.65
Employees	27	Current Ratio	13.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	75.99	Volatility	7.79% 9.90%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-24.30%	Profit Margin	-	Rel Volume	2.49	Prev Close	9.35
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	7.55K	Price	9.89
Recom	2.00	SMA20	34.49%	SMA50	56.46%	SMA200	48.20%	Volume	18,798	Change	5.78%

May-11-20

Resumed

Craig Hallum

Buy

Nov-20-18

Initiated

H.C. Wainwright

Buy

$36

Nov-09-20 04:00PM	Celcuity Reports Third Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Oct-26-20 03:15PM	Celcuity Inc. Schedules Release of Third Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Oct-04-20 09:30AM	Celcuity (NASDAQ:CELC) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
09:30AM	Celcuity (NASDAQ:CELC) Is In A Good Position To Deliver On Growth Plans CoinDesk
Aug-27-20 09:45AM	Celcuity to Present at the LD Micro 500 Investor Conference ACCESSWIRE
Aug-10-20 04:00PM	Celcuity Reports Second Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE
Jul-24-20 04:45PM	Celcuity Inc. Schedules Release of Second Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Jul-01-20 05:30PM	Celcuity Hosting Call on CELsignia Pathway Activity Test for Ovarian Cancer ACCESSWIRE
Jun-22-20 07:00PM	Celcuity Presents Data at AACR Annual Meeting for CELsignia Pathway Activity Test for Ovarian Cancer ACCESSWIRE +8.43%
May-07-20 04:00PM	Celcuity Reports First Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE -5.00%
Apr-23-20 04:40PM	Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Apr-07-20 09:23AM	Here's Why We're Not Too Worried About Celcuity's (NASDAQ:CELC) Cash Burn Situation Simply Wall St. -15.51%
Mar-12-20 04:00PM	Celcuity Reports Fourth Quarter and Full Year 2019 Financial Results ACCESSWIRE -5.48%
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-20 04:15PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call ACCESSWIRE
Dec-12-19 11:07AM	The Zacks Analyst Blog Highlights: Red Robin, Celcuity, Atlas Air and Boston Private Zacks
Dec-11-19 07:25PM	Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors ACCESSWIRE
08:34AM	4 Small Cap Stocks to Get Rid of Before Entering 2020 Zacks
Dec-05-19 10:24AM	Celcuity Announces Appointment of Richard Buller to Board of Directors Business Wire
Nov-07-19 04:01PM	Celcuity Reports Third Quarter 2019 Financial Results Business Wire
Nov-01-19 09:00AM	All You Need to Know About Celcuity, Inc. (CELC) Rating Upgrade to Buy Zacks
Oct-28-19 11:28AM	What Kind Of Investor Owns Most Of Celcuity Inc. (NASDAQ:CELC)? Simply Wall St.
Oct-24-19 03:31PM	Celcuity Inc. Schedules Release of Third Quarter 2019 Financial Results and Conference Call Business Wire
Sep-24-19 08:50AM	Paratek Pharmaceuticals (PRTK) Catches Eye: Stock Jumps 10.2% Zacks
Sep-11-19 11:37AM	Ultragenyx to Submit sBLA for Label Expansion of Crysvita Zacks
Sep-10-19 09:01AM	Adaptimmune (ADAP) Gets Orphan Drug Status for T-cell Therapy Zacks
07:59AM	Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review Zacks
Sep-09-19 09:37AM	Celcuity Announces Appointment of Eric Lindquist as Chief Business Officer Business Wire
Aug-19-19 05:55PM	Nabriva (NBRV) Aims to Resubmit Contepo NDA in Q4 Zacks
09:00AM	Celcuity, Inc. (CELC) Upgraded to Strong Buy: Here's Why Zacks
Aug-08-19 04:00PM	Celcuity Reports Second Quarter 2019 Financial Results Business Wire
Jul-25-19 03:34PM	Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call Business Wire
Jun-27-19 09:00AM	What Makes Celcuity, Inc. (CELC) a New Strong Buy Stock Zacks +8.37%
May-20-19 02:36PM	Celcuity Announces Appointment of Leo Furcht to Board of Directors Business Wire
May-13-19 09:00AM	Celcuity, Inc. (CELC) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-07-19 04:01PM	Celcuity Reports First Quarter 2019 Financial Results Business Wire
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Apr-29-19 10:50AM	Introducing Celcuity (NASDAQ:CELC), A Stock That Climbed 15% In The Last Year Simply Wall St.
Apr-23-19 01:48PM	Celcuity Inc. Schedules Release of First Quarter 2019 Financial Results and Conference Call Business Wire
Apr-12-19 08:50AM	Autolus Therapeutics (AUTL) Catches Eye: Stock Jumps 5.6% Zacks
Apr-10-19 08:45AM	InflaRx (IFRX) Catches Eye: Stock Jumps 7.5% Zacks
Apr-04-19 08:33AM	Nabriva Therapeutics (NBRV) in Focus: Stock Moves 7.5% Higher Zacks
Mar-07-19 08:58AM	Krystal (KRYS) in Focus: Stock Moves 5.1% Higher Zacks
Mar-05-19 08:48AM	MyoKardia (MYOK) in Focus: Stock Moves 7.3% Higher Zacks -5.01%
Feb-26-19 09:20PM	Celcuity Inc. (CELC) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM	Celcuity Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
Feb-14-19 05:12PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2018 Financial Results and Conference Call Business Wire
Dec-25-18 03:00PM	What Percentage Of Celcuity Inc. (NASDAQ:CELC) Shares Do Insiders Own? Simply Wall St.
Dec-11-18 08:10AM	Consolidated Research: 2018 Summary Expectations for IRHYTHM TECH, ON Semiconductor, CryoPort, Celcuity, InnerWorkings, and AgroFresh Solutions Fundamental Analysis, Key Performance Indications GlobeNewswire -8.88%
Dec-07-18 06:33PM	Celcuity Presents Results from Three Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and Co-Activated HER Family and c-Met Signaling Business Wire
Nov-13-18 04:00PM	Celcuity Reports Third Quarter 2018 Financial Results Business Wire
Oct-31-18 08:00AM	HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President GlobeNewswire
Oct-30-18 04:56PM	Celcuity Inc. Schedules Release of Third Quarter 2018 Financial Results and Conference Call Business Wire
Oct-19-18 07:45AM	Detailed Research: Economic Perspectives on BeiGene, Costco Wholesale, Rogers, Advance Auto Parts, Celcuity, and Harris What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-16-18 05:51PM	Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center Business Wire
Aug-09-18 04:00PM	Celcuity Reports Second Quarter 2018 Financial Results Business Wire
02:30PM	Celcuity Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:31PM	Celcuity Inc. Schedules Release of Second Quarter 2018 Financial Results and Conference Call Business Wire
May-14-18 04:00PM	Celcuity Reports First Quarter 2018 Financial Results Business Wire
May-02-18 12:28PM	Celcuity Inc. Schedules Release of First Quarter 2018 Financial Results and Conference Call Business Wire
Mar-19-18 07:33AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Celcuity Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-15-18 04:00PM	Celcuity Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
Mar-02-18 04:00PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2017 Financial Results and Conference Call Business Wire
Jan-19-18 07:30AM	Investor Expectations to Drive Momentum within Advanced Micro Devices, Knoll, Hubbell, Celcuity, SecureWorks, and First Foundation Discovering Underlying Factors of Influence GlobeNewswire
Nov-13-17 07:00AM	Celcuity Reports Third Quarter Fiscal 2017 Financial Results Business Wire
Nov-02-17 01:08PM	Celcuity Inc. Schedules Release of Third Quarter Fiscal 2017 Financial Results and Conference Call Business Wire
Oct-31-17 09:15PM	Is Celcuity Incs (CELC) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Sep-24-17 09:57AM	IPO News This Week: Roku, PQ Group Lead 7 Offerings Due Out 24/7 Wall St.
Sep-22-17 04:05PM	Celcuity Announces Closing of Initial Public Offering Business Wire
Sep-20-17 06:00AM	Celcuity Announces Pricing of Initial Public Offering Business Wire

Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It develops CELsignia HSF test to diagnose two new sub-types of HER2-negative breast cancer. The company is also developing CELsignia MP test to diagnose 11 cancer sub-types in breast, lung, colon, ovarian, kidney, and bladder cancers. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience